Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Posters

Search Title by author or title

Posterior chamber phakic intraocular lens for hyperopia between years 2006 – 2015

Poster Details

First Author: s. soria ARGENTINA

Co Author(s):    A. Chialvo   M. Canepa   P. Coccaro   P. Güereña   A. Bejarsky   N. Feola     

Abstract Details

Purpose:

to asses the clinical outcomes of implantable collamer lens (vision icl; staar surgical) implantation for hyperopia between years 2006-2015

Setting:

Clinica Privada de Ojos, Mar del Plata, Buenos Aires, Argentina

Methods:

43 eyes of 24 patients with hyperopia had implantation of an ICL between the years 2006 and 2015. 5 patients had implantation in one eye and 19 in both eyes. Patients were examined preoperatively and 1 day, 10 days, 1 month and 1 year postoperatively. Main outcome measures were subjective and objective refractions, uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), endothelial cells count, adverse efects and cataract formation

Results:

The mean MD preoperatory spherical refraction was + 3,72 +/- 1,43 SD, (range + 1,25 to + 7,25). Mean cylinder was + 1,1 +/- 1,08 SD (range 0 to 0,9 logMAR). Mean endothelial cells count were 2701, 17 +/- 326, 71 (range 2079 to 3354). All surgerys were uneventful. One year postoperatory, mean uncorrected visual acuity was 0,17 logMAR +/- 0,18 logMAR (range 0 to 0,7). BCVA was 0,14 logMAR +/- 0,17 logMAR SD (range 0 to 0,6). Refraction was 0,15 +/- 0,36 (range -0,75 to +1). Mean endothelial cells count was 2613,25 +/- 308, 93 (range 2034 to 3165). There was no cataract formation

Conclusions:

Posterior chamber phakic intraocular lens (ICL) implantation is safe and effective in the treatment of hyperopia

Financial Disclosure:

NONE

Back to Poster listing